MedPath

Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO
Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Associated Conditions
Agitation, Alcohol Withdrawal Syndrome
Associated Therapies
-

The Effects of Mild Sedation on Motor Function Networks in Patients With Brian Gliomas

Not Applicable
Recruiting
Conditions
Brain Glioma
Interventions
First Posted Date
2019-06-12
Last Posted Date
2023-07-27
Lead Sponsor
Beijing Tiantan Hospital
Target Recruit Count
100
Registration Number
NCT03984240
Locations
🇨🇳

Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China

Sedation Strategies for Diagnostic Bronchoscopy 2

Not Applicable
Conditions
Bronchoscopy
Sedation
Interventions
First Posted Date
2019-06-12
Last Posted Date
2019-06-14
Lead Sponsor
Changhai Hospital
Target Recruit Count
200
Registration Number
NCT03983889
Locations
🇨🇳

Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China

Sedation Strategies for Therapeutic Bronchoscopy 2

Not Applicable
Conditions
Bronchoscopy
Sedation
Interventions
First Posted Date
2019-06-12
Last Posted Date
2019-06-14
Lead Sponsor
Changhai Hospital
Target Recruit Count
80
Registration Number
NCT03983915
Locations
🇨🇳

Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China

The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy

Not Applicable
Completed
Conditions
Gastric Cancer
Gastrostomy
Interventions
First Posted Date
2019-05-23
Last Posted Date
2020-09-28
Lead Sponsor
Yonsei University
Target Recruit Count
84
Registration Number
NCT03960775
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of

Intranasal Dexmedetomidine Dose-finding Study

Phase 2
Completed
Conditions
Laceration Repair
Interventions
First Posted Date
2019-05-21
Last Posted Date
2022-04-07
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
55
Registration Number
NCT03957304
Locations
🇨🇦

London Health Sciences Centre, London, Ontario, Canada

Dexmedetomidine and Delirium in Elderly Patients

Not Applicable
Conditions
Delirium, Dexmedetomidine, Postoperative PCA
Interventions
Drug: Dexmedetomidine
Drug: Fentanyl-based PCA infusion
First Posted Date
2019-05-06
Last Posted Date
2022-03-31
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
60
Registration Number
NCT03938831
Locations
🇰🇷

KoreaUniversity Guro Hospital, Seoul, Guro-ku, Korea, Republic of

DOSE Trial of Opioid Sparing Effect

Phase 1
Terminated
Conditions
Mechanical Ventilation Complication
Critically Ill
Dexmedetomidine
Interventions
First Posted Date
2019-05-06
Last Posted Date
2021-11-05
Lead Sponsor
Duke University
Target Recruit Count
30
Registration Number
NCT03938857
Locations
🇺🇸

Rainbow Babies and Children's Hospital, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

🇺🇸

MetroHealth System, Case CTSA, Cleveland, Ohio, United States

🇺🇸

Arkansas Children's Hospital, Little Rock, Arkansas, United States

and more 16 locations

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Phase 2
Completed
Conditions
Refractory Pain
Metastatic Cancer
Interventions
First Posted Date
2019-05-03
Last Posted Date
2019-05-14
Lead Sponsor
Hotel Dieu de France Hospital
Target Recruit Count
18
Registration Number
NCT03936205

Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes

Phase 4
Active, not recruiting
Conditions
High-risk Patients
Abdominal Surgery
Dexmedetomidine
Postoperative Complications
Blood Pressure
Interventions
Drug: Placebo
Drug: Dexmedetomidine
Other: Routine blood pressure management
Other: Goal-directed blood pressure management
First Posted Date
2019-05-01
Last Posted Date
2024-03-13
Lead Sponsor
Peking University First Hospital
Target Recruit Count
496
Registration Number
NCT03933306
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

Conscious Sedation for Cataract Operations Under Topical Anaesthesia

First Posted Date
2019-05-01
Last Posted Date
2021-01-08
Lead Sponsor
Menoufia University
Target Recruit Count
100
Registration Number
NCT03933280
Locations
🇪🇬

Faculty of Medicine, Cairo, Shebin El-kom, Egypt

© Copyright 2025. All Rights Reserved by MedPath